# OnCo record guardant-reveal (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/guardant-reveal/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "guardant-reveal" ;
  schema:name "Guardant Reveal"@en ;
  schema:description "A blood test for leftover cancer after surgery that needs no tumour sample, so results come faster than tumour-informed tests."@en ;
  schema:url <https://onco.cc/drugs/guardant-reveal/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://guardanthealth.com/> ;
  onco:status "established" ;
  onco:tag "test" ;
  onco:modality "Tumour-naive ctDNA minimal residual disease test (methylation and genomic)" ;
  schema:alternateName "Guardant Reveal" ;
  onco:related <https://onco.cc/drugs/signatera/>, <https://onco.cc/drugs/radar-mrd/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:companies <https://onco.cc/companies/guardant-health/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> ;
  onco:trials <https://onco.cc/trials/nct07802626/> .